Refeyn strengthens capability with new US Headquarters in Boston area

FHS
May 23, 2024
11:58 am

Refeyn, the pioneer of mass photometry technology, is continuing to strengthen the deployment of its unique bioanalytical tools with the planned Grand Opening of its new US Headquarters and Customer Interaction Center, in conjunction with the third annual Mass Photometry Summit 2024. Following the summit, highlighting the very latest advances in mass photometry, to be held in the Boston area on May 22, Refeyn will officially open its new 10,000 sq. ft. HQ in the heart of Waltham’s Biotech Hub in Greater Boston, Massachusetts, on May 23.

CBD and THC: promising remedies for aluminum-related neurological damage

Researchers assessed the protective effect of CBD and THC oils against aluminum toxicity.

June 20, 2023

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,

June 19, 2024

Study reveals lasting lung damage in tuberculosis survivors

New research being presented at this year’s ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found compelling evidence that tuberculosis (TB) can

April 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.